Corporate Overview


Corporate Overview


Show events starting after a certain date (e.g. now, -1 year, -5 months, -4 hours, or +1 hour)
Show events starting before a certain date (e.g. +1 year, +5 months, +4 hours, or -1 hour)

Recent News

VALLEY FORGE, Pa. --(BUSINESS WIRE)--Feb. 7, 2018-- The Board of Directors of  AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.38 per common share, payable March 5, 2018, to stockholders of record at the close of business on February 20, 2018.
Revenues of $40.5 Billion for the First Quarter, a 6.0 Percent Increase Year-Over-Year First Quarter GAAP Diluted EPS of $3.90 and Adjusted Diluted EPS of $1.55 Adjusted Diluted EPS Guidance Raised to $6.45 to $6.65 for Fiscal Year 2018, Primarily Driven by U.S. Tax Reform Benefit VALLEY FORGE, Pa.
VALLEY FORGE, Pa. --(BUSINESS WIRE)--Jan. 8, 2018-- AmerisourceBergen Corporation (NYSE:ABC) today announced that it plans to release its results for the First Quarter Fiscal 2018 on Tuesday, February 6, 2018 prior to the opening of trading on the New York Stock Exchange .

Investor & Media Inquiries

Keri P. Mattox
Vice President, Corporate & Investor Relations
Phone: 610-576-7801


Bennett S. Murphy
Director, Corporate & Investor Relations
Phone: 610-727-3693

Contact Information

P.O. Box 959
Valley Forge, PA 19482


Phone Number


Transfer Agent
P.O. Box 43078
Providence, RI 02940-3078
Phone: 866-233-1957
Corporate Website:

Marsh Risk & Insurance Services
4695 MacArthur Court
Newport Beach, CA 92660

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More